Research progress of miR-451 in tumor

Abstract

南Yang , ZHONG Yue. Research progress of miR-451 in tumor[J]. Journal of International Oncology, 2014, 41(12): 887-890.

［1］ Gal H, Pandi G, Kanner AA, et al. MIR451 and Imatinib mesylate inhibit tumor growth of Glioblastoma stem cells［J］. Biochem Biophys Res Commun, 2008, 376(1): 8690. ［2］ Godlewski J, Nowicki MO, Bronisz A, et al. MicroRNA451 regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cells［J］. Mol Cell, 2010, 37(5): 620632. ［3］ Godlewski J, Bronisz A, Nowicki MO, et al. microRNA451: A conditional switch controlling glioma cell proliferation and migration［J］. Cell Cycle, 2010, 9(14): 27422748. ［4］ Zhou X, Ren Y, Moore L, et al. Downregulation of miR21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status［J］. Lab Invest, 2010, 90(2): 144155. ［5］ Nan Y, Han L, Zhang A, et al. MiRNA451 plays a role as tumor suppressor in human glioma cells［J］. Brain Res, 2010, 1359: 1421. ［6］ Tian Y, Nan Y, Han L, et al. MicroRNA miR451 downregulates the PI3K/AKT pathway through CAB39 in human glioma［J］. Int J Oncol, 2012, 40(4):11051112. ［7］ Wang R, Wang ZX, Yang JS, et al. MicroRNA451 functions as a tumor suppressor in human nonsmall cell lung cancer by targeting rasrelated protein 14 (RAB14) ［J］. Oncogene, 2011, 30(23): 26442658. ［8］ Gao W, Shen H, Liu L, et al. MiR21 overexpression in human primary squamous cell lung carcinoma is associated with poor patient prognosis［J］. J Cancer Res Clin Oncol, 2011, 137(4): 557566. ［9］ Bian HB, Pan X, Yang JS, et al. Upregulation of microRNA451 increases cisplatin sensitivity of nonsmall cell lung cancer cell line (A549) ［J］. J Exp Clin Cancer Res 2011, 30: 20. ［10］ Bandres E, Bitarte N, Arias F, et al. microRNA451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells［J］. Clin Cancer Res, 2009, 15(7): 22812290. ［11］ Zhu C, Ren C, Han J, et al. A fivemicroRNA panel in plasma was identified as potential biomarker for early detection of gastric cancer［J］. Br J Cancer, 2014, 110(9): 22912299. ［12］ Li HP, Zeng XC, Zhang B, et al. miR451 inhibits cell proliferation in human hepatocellular carcinoma through direct suppression of IKKβ［J］. Carcinogenesis, 2013, 34(11): 24432451. ［13］ Liu X, Zhang X, Xiang J, et al. miR451: Potential role as tumor suppressor of human hepatoma cell growth and invasion［J］. Int J Oncol, 2014, 45(2): 739745. ［14］ Li HY, Zhang Y, Cai JH, et al. MicroRNA451 inhibits growth of human colorectal carcinoma cells via downregulation of Pi3k/Akt pathway［J］. Asian Pac J Cancer Prev, 2013, 14(6): 36313634. ［15］ Shivapurkar N, Weiner LM, Marshall JL, et al. Recurrence of early stage colon cancer predicted by expression pattern of circulating microRNAs［J］. PLoS One, 2014, 9(1):e84686. ［16］ Kovalchuk O, Filkowski J, Meservy J, et al. Involvement of microRNA451 in resistance of the MCF7 breast cancer cells to chemotherapeutic drug doxorubicin［J］. Mol Cancer Ther, 2008, 7(7): 21522159. ［17］ Ji T, Zheng ZG, Wang FM, et al. Differential microRNA expression by Solexa sequencing in the sera of ovarian cancer patients［J］. Asian Pac J Cancer Prev, 2014, 15(4):17391743. ［18］ Gits CM, van Kuijk PF, Jonkers MB, et al. MicroRNA expression profiles distinguish liposarcoma subtypes and implicate miR145 and miR451 as tumor suppressors［J］. Int J Cancer, 2014, 135(2): 348361. ［19］ Xu H, Mei Q, Shi L, et al. Tumorsuppressing effects of miR451 in human osteosarcoma［J］. Cell Biochem Biophys, 2014, 69(1): 163168. ［20］ Liu N, Jiang N, Guo R, et al. MiR451 inhibits cell growth and invasion by targeting MIF and is associated with survival in nasopharyngeal carcinoma［J］. Mol Cancer, 2013, 12(1): 123. ［21］ Wang T, Zang WQ, Li M, et al. Effect of miR451 on the biological behavior of the esophageal carcinoma cell line EC9706［J］. Dig Dis Sci, 2013, 58(3): 706714. ［22］ Redova M, Poprach A, Nekvindova J ,et al. Circulating miR378 and miR451 in serum are potential biomarkers for renal cell carcinoma［J］. J Transl Med, 2012, 10: 55. ［23］ Caruso P, MacLean MR, Khanin R, et al. Dynamic changes inlung microRNA profiles during the development of pulmonary hypertension due to chronic hypoxia and monocrotaline［J］. Arterioscler Thromb Vasc Biol, 2010, 30(4): 716723. ［24］ Liu D, Liu C, Wang X, et al. MicroRNA451 suppresses tumor cell growth by downregulating IL6R gene expression［J］. Cancer Epidemiol, 2014, 38(1): 8592.

[1]	Gong Yan, Chen Honglei.Research progress on the mechanism of microRNA regulation of cisplatin resistance in ovarian cancer[J]. Journal of International Oncology, 2024, 51(3): 186-190.
[2]	Quan Zhenhao, Xu Feipeng, Huang Zhe, Huang Xianjin, Chen Rihong, Sun Kaiyu, Hu Xu, Lin Lin.lncRNA FTX silencing inhibits gastric cancer cell proliferation through the miR-22-3p/NLRP3 inflammasome pathway[J]. Journal of International Oncology, 2023, 50(4): 202-207.
[3]	Zhou Renbang, Zhang Zhongchuan, Xu Zhiyuan, Zhu Xunbing.MiR-219a-5p inhibits the proliferation, invasion and migration of osteosarcoma U2OS cells by negatively regulating HMGA2[J]. Journal of International Oncology, 2022, 49(4): 193-198.
[4]	Jin Jiahui, Chen Cunhai, Ma Xuezhen.Effects of radiation-associated miRNA in radiotherapy for breast cancer[J]. Journal of International Oncology, 2022, 49(12): 735-738.
[5]	Jing Wenjun, Zhao Wenwen, Feng Qingqing, Zhao Wenfei, Zhao Lili, Zhang Xue, Wei Hongmei.Molecular basis and clinical prospect of the miR-34 family for the treatment of gastric cancer[J]. Journal of International Oncology, 2022, 49(11): 681-686.
[6]	Luo Liyun, Lai Canhui, Liang Renpei, Yang Aiwu, Lin Zhimin.Correlation between the expressions of miR-524-5p and SOX9 in advanced gastric cancer and their influences on chemotherapy efficacy and prognosis[J]. Journal of International Oncology, 2022, 49(1): 45-50.
[7]	Hong Anlan, Cao Meng, Wang Yan, Fang Fang.Research progress on lncRNAs as members of ceRNA network in melanoma[J]. Journal of International Oncology, 2022, 49(1): 61-64.
[8]	Liu Pei, Pu Jiaze, Huang Wen, Wang Fei.Expression differences of miR-200c, miR-19a and miR-155 in gefitinib sensitive and drug resistant NSCLC patients and their effects on prognosis[J]. Journal of International Oncology, 2021, 48(7): 409-414.
[9]	Wang Yang, Liu Qian, Long Hui, Wu Qingming.Research status of fecal detection for colorectal cancer markers[J]. Journal of International Oncology, 2021, 48(7): 441-444.
[10]	Cheng Yiming, Li Gang, Wang Zhenming, Lyu Qianwen, Li Shirong.Value of serum miR-196a-5p and miR-105-5p in differential diagnosis of benign and malignant pulmonary nodules[J]. Journal of International Oncology, 2021, 48(5): 282-286.
[11]	Deng Bo'er, Kong Weimin.Epigenetic research progress of endometrial cancer[J]. Journal of International Oncology, 2021, 48(3): 184-188.
[12]	Li Bingliang, Yang Ya, Huang Yingli, Si Wen, Li Xingwei, Zhang Yuanmin, Bian Jichao, Chen Yu.Effects of miR-20a-5p targeting KDM6B on the proliferation, migration and invasion of osteosarcoma cells[J]. Journal of International Oncology, 2021, 48(2): 65-73.
[13]	He Miao, Fan Kui, Cao Fang.Epigenetics and drug resistance in lung cancer[J]. Journal of International Oncology, 2021, 48(10): 622-626.
[14]	Zhou Jiamin, Ye Lisha, Wang Guohua.Roles of microRNA in the regulation of tumor-associated macrophage polarization during the remodeling of breast cancer immune microenvironment[J]. Journal of International Oncology, 2020, 47(7): 428-430.
[15]	Yang Lifen, Song Wei, Xu Dawei, Wu Jun, Gao Ran.Mechanisms of miR-103a-3p/CHI3L1 in proliferation and vascular mimicry of ovarian cancer cells[J]. Journal of International Oncology, 2020, 47(6): 333-339.

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles15

Recommended Articles

Metrics

Comments